Oric Pharmaceuticals
ORIC
ORIC
70 hedge funds and large institutions have $189M invested in Oric Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 12 closing their positions.
Holders
70
Holders Change
+6
Holders Change %
+9.38%
% of All Funds
1.12%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.1%
New
18
Increased
18
Reduced
17
Closed
12
Calls
$163K
Puts
$117K
Net Calls
+$46K
Net Calls Change
-$804K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$12.9M |
| 2 |
PM
2
Prosight Management
Dallas,
Texas
|
$8.81M |
| 3 |
UOC
3
UBS O'Connor
Chicago,
Illinois
|
$2.07M |
| 4 |
SCM
4
Silverarc Capital Management
Boston,
Massachusetts
|
$8.18M |
| 5 |
5
Jane Street
New York
|
$987K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
E
76
Ergoteles
New York
| – | -$250K | -42,523 | Closed |
|
|
PCM
77
Prelude Capital Management
New York
| – | -$90.4K | -15,353 | Closed |
|
|
BIAS
78
Beacon Investment Advisory Services
Morristown,
New Jersey
| – | -$88.4K | -15,000 | Closed |
|
|
WIA
79
World Investment Advisors
Santa Barbara,
California
| – | -$63K | -10,700 | Closed |
|
|
TRCT
80
Tower Research Capital (TRC)
New York
| – | -$53K | -9,077 | Closed |
|
81
UBS Group
Zurich,
Switzerland
| – | -$26.1K | -4,433 | Closed |
|